Loading…

Alcohol and substance use diagnoses among HIV-positive patients receiving care in NYC clinic settings

•Immunocompromised patients were found to be lower in the reference group.•The reference group was significantly younger than the three comparison groups.•Diagnosis of alcohol and drug use was significantly associated.•Higher proportion of patients in all three comparison groups had an inpatient sta...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol dependence 2017-11, Vol.180, p.62-67
Main Authors: Gurung, Sitaji, Ventuneac, Ana, Cain, Demetria, Mirzayi, Chloe, Ferraris, Christopher, Rendina, H. Jonathon, Sparks, Martha A., Parsons, Jeffrey T.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Immunocompromised patients were found to be lower in the reference group.•The reference group was significantly younger than the three comparison groups.•Diagnosis of alcohol and drug use was significantly associated.•Higher proportion of patients in all three comparison groups had an inpatient stay.•HIV treatment providers should routinely screen for alcohol and substances. Substance use among HIV-positive persons exacerbates health problems. This study sought to estimate the prevalence of alcohol and drug-use diagnoses and examined hypothesized predictors associated with alcohol and drug-use diagnoses among HIV-positive patients in New York City (NYC). This cohort study reviewed electronic medical records (EMRs) of 4965 HIV-positive patients based on diagnostic codes. These patients attended a comprehensive care clinic in NYC in 2012. Multinomial logistic regression was used to predict the odds of classification into substance use diagnosis grouping. Of the full sample, only 12.7% of patients had an alcohol use diagnosis documented in their EMR compared with more than one-quarter (26.4%) of patients having a recorded drug use diagnosis (p
ISSN:0376-8716
1879-0046
DOI:10.1016/j.drugalcdep.2017.07.034